Recombinant Legionella pneumophila tRNA pseudouridine synthase A (truA)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We preferentially ship the in-stock format. For specific format requirements, please note them when ordering.
Lead Time
Delivery time varies by purchasing method and location. Consult local distributors for specifics. Proteins ship with blue ice packs. For dry ice shipping, contact us in advance (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Default glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
truA; LPC_0727; tRNA pseudouridine synthase A; EC 5.4.99.12; tRNA pseudouridine(38-40) synthase; tRNA pseudouridylate synthase I; tRNA-uridine isomerase I
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-262
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Legionella pneumophila (strain Corby)
Target Names
truA
Target Protein Sequence
MRIALVVEYD GSQYHGWQAQ TGLHTIQQAV EFALSKVADS SISVVCAGRT DTGVHATNQV IHFDCEKDRS IRAWIHGANT FLPKDICVKW GKEMPENFHA RYSAVSRRYR YVIYNGAIRP GLLRGNVTWQ YRQLDHRLMQ QGGQCLLGEN DFTSFRSVEC QSNTPMRNIH QLQVTRHGDL VVLDITANAF LHHMVRNIAG VLIAVGSGKH PVGWVKDVLN AKDRKLGAET APSYGLYLVQ VTYPKEFGLL QNNPGPLFLW EK
Uniprot No.

Target Background

Function
Forms pseudouridine at positions 38, 39, and 40 in the anticodon stem and loop of transfer RNAs.
Database Links

KEGG: lpc:LPC_0727

Protein Families
TRNA pseudouridine synthase TruA family

Q&A

What is tRNA pseudouridine synthase A (truA) in Legionella pneumophila?

TruA is an enzyme that catalyzes the formation of pseudouridine in tRNA molecules, specifically at positions 38-40 in the anticodon stem loop. In Legionella pneumophila, this enzyme is critical for proper translation of genetic material and may influence bacterial virulence. TruA belongs to the pseudouridine synthase family, which is responsible for one of the most common RNA modifications across all domains of life . Unlike its relative TruB which modifies U55 in the T-arm of tRNAs, truA targets different positions and may have distinct structural features that allow for its specific binding to substrate RNAs .

How does truA differ from other pseudouridine synthases in L. pneumophila?

While both truA and other pseudouridine synthases like truB catalyze the conversion of uridine to pseudouridine, they differ in their target sites and structural features. TruB, for example, recognizes and modifies U55 in the T-arm of tRNAs, utilizing a combination of rigid docking and induced fit mechanisms . By comparison, truA targets positions 38-40 in the anticodon stem loop. Structurally, these enzymes likely share the core catalytic domain but differ in their RNA recognition regions, which determine their specificity. The binding mechanism of truA may involve similar conformational changes as observed with TruB, including the ordering of loop regions upon substrate binding and domain movements to maximize RNA interactions .

What expression systems are most effective for producing recombinant L. pneumophila truA?

For recombinant production of L. pneumophila truA, multiple expression systems have proven effective, with E. coli being the most commonly used due to its simplicity and high yield. Yeast, baculovirus, and mammalian cell systems are alternative options for expression when proper folding or post-translational modifications are concerns . The choice of expression system should be guided by the specific research needs:

Expression SystemAdvantagesChallengesBest Used For
E. coliHigh yield, economical, rapid expressionPotential misfolding of complex proteinsBasic structural studies, antibody production
YeastBetter folding of eukaryotic-like proteinsLonger production timeFunctional studies requiring proper folding
BaculovirusExcellent for large or complex proteinsTechnical complexity, costlyHigh-quality structural analysis
Mammalian cellsNative-like post-translational modificationsMost expensive, lowest yieldFunctional studies requiring authentic modifications

When expressing truA in E. coli, optimization of induction conditions (temperature, IPTG concentration) and the addition of specific chaperones may improve soluble protein yield.

What purification strategies yield the highest activity for recombinant truA?

A multi-step purification strategy typically yields the highest activity for recombinant truA. The process generally involves:

  • Initial Capture: Affinity chromatography using His-tag or GST-tag systems to capture the recombinant protein from cell lysate

  • Intermediate Purification: Ion exchange chromatography to separate based on charge properties

  • Polishing: Size exclusion chromatography to obtain highly pure protein

Temperature control during purification (usually 4°C) and the inclusion of reducing agents (like DTT or β-mercaptoethanol) help maintain enzyme activity by preventing oxidation of critical cysteine residues. Enzyme stability can be enhanced by including glycerol (10-20%) in storage buffers. Activity assays should be performed immediately after purification to confirm enzyme functionality, typically measuring the conversion of uridine to pseudouridine in RNA substrates through methods such as HPLC, mass spectrometry, or radioisotope labeling .

How can I design RNA substrates to assess truA activity in vitro?

For in vitro assessment of truA activity, synthetic RNA substrates should be designed to mimic the natural tRNA targets. Based on knowledge from related tRNA pseudouridine synthases, effective substrate design should include:

  • Minimal Substrate Approach: Synthesize RNA oligonucleotides containing the anticodon stem-loop region with potential modification sites (positions 38-40)

  • Full tRNA Approach: Use in vitro transcribed full-length tRNAs to assess activity in a more native context

RNA substrates can be labeled with radioisotopes (³²P) or fluorescent tags for detection purposes. Drawing from studies on TruB, which recognizes its RNA substrate through specific structural interactions, the RNA substrates for truA would likely need to maintain certain structural features for proper enzyme recognition . Control substrates with altered sequences at the target sites can help establish specificity of the enzyme activity.

What structural features enable truA to recognize its specific tRNA targets?

While specific structural data for L. pneumophila truA is limited, insights can be gained from related tRNA pseudouridine synthases like TruB. Based on these homologies, truA likely recognizes its tRNA targets through multiple mechanisms:

  • Thumb Loop Interaction: Similar to TruB's "thumb loop" that binds into the RNA hairpin loop, truA may possess a comparable structural element that interacts with the anticodon loop

  • Domain Movement: A hinge movement of domains upon RNA binding, analogous to the 10° hinge movement observed in TruB's C-terminal domain

  • Combined Recognition Mechanism: Like TruB, truA likely employs a "rigid docking and induced fit" mechanism, first binding to target RNA through conserved motifs, then undergoing conformational changes to maximize interaction

The catalytic site of truA probably contains an aspartic acid residue essential for the isomerization reaction, positioned to interact with the target uridine residue in the RNA substrate.

How does the structure of truA compare across different Legionella species?

Comparative analysis of truA across Legionella species reveals a high degree of conservation in the catalytic domain, with greater variability in the RNA recognition regions. This pattern reflects evolutionary pressure to maintain the core enzymatic function while allowing adaptation to different tRNA structures or regulatory mechanisms across species.

Based on population structure studies of L. pneumophila, truA likely exhibits sequence variations that align with the broader genomic classification of strains into distinct MCG (minimum core genome) groups . These variations may contribute to the phenotypic differences observed between strains, including potentially their intracellular growth abilities, as certain MCG groups demonstrate higher intracellular growth capacity than others .

What are the critical amino acid residues for truA catalytic activity?

While specific data for L. pneumophila truA is not directly provided in the search results, research on homologous tRNA pseudouridine synthases suggests several critical residues likely essential for catalytic activity:

  • Catalytic Aspartate: A conserved aspartic acid residue that serves as the catalyst for the isomerization reaction

  • Aromatic Residues: Typically, tyrosine or phenylalanine residues that stack with the target uracil

  • Basic Residues: Lysine or arginine residues that interact with the RNA phosphate backbone

Site-directed mutagenesis studies targeting these predicted residues would be necessary to definitively establish their roles in L. pneumophila truA. Comparative analysis with the well-studied TruB enzyme could guide the identification of these critical residues, as TruB's mechanism involves both rigid binding to target RNA and subsequent induced conformational changes that maximize enzyme-substrate interaction .

How does truA contribute to the virulence mechanism of L. pneumophila?

The contribution of truA to L. pneumophila virulence likely stems from its role in ensuring proper translation through tRNA modification. While not directly identified as a virulence factor in the provided search results, several points suggest potential involvement in pathogenicity:

  • Translational Fidelity: By modifying tRNAs, truA may ensure accurate translation of virulence-associated proteins, particularly under stress conditions encountered during infection

  • Potential Regulation of Virulence Factors: Similar to how some L. pneumophila effectors manipulate host cell functions (such as phospholipid biosynthesis mentioned in source ), properly modified tRNAs may be critical for the expression of these effectors

  • Growth in Host Cells: L. pneumophila strains have varying intracellular growth abilities , and proper tRNA modification may contribute to optimal growth within host cells

Research investigating truA knockout mutants and their ability to replicate within amoebae or macrophages would provide direct evidence for its role in virulence, similar to studies on other Legionella effectors that show effects on intracellular growth .

How is truA expression regulated during different life stages of L. pneumophila?

L. pneumophila exhibits distinct life stages during its infectious cycle, from the replicative phase to the transmissive phase. Proteome studies suggest differential expression of proteins across these life stages , though specific data on truA regulation is not provided in the search results.

Based on general principles of bacterial gene regulation and the importance of RNA modification enzymes:

  • Growth Phase-Dependent Expression: truA may be upregulated during active replication when demand for translation is highest

  • Stress Response Regulation: Under stress conditions (such as nutrient limitation or host defense mechanisms), truA expression might be altered to optimize bacterial survival

  • Temperature-Dependent Regulation: Given that L. pneumophila transitions between environmental water sources and human hosts, temperature shifts may trigger changes in truA expression

Research methods to study this regulation would include quantitative PCR, proteomics, and reporter gene assays under various growth conditions to track truA expression levels across different life stages.

Could truA serve as a potential target for novel antimicrobial therapies against Legionella infections?

TruA could potentially serve as a target for novel antimicrobial therapies based on several factors:

  • Essential Function: If truA is essential for L. pneumophila viability or virulence, inhibiting it could effectively control infection

  • Conservation: As potentially part of the minimum core genome (MCG) of L. pneumophila , truA may be sufficiently conserved to allow development of broadly effective inhibitors

  • Structural Distinctiveness: If structural differences exist between bacterial and human pseudouridine synthases, selective targeting may be possible

The development of such therapeutics would require:

  • Structural Studies: Crystal structures of L. pneumophila truA to identify targetable pockets

  • High-throughput Screening: Identification of compounds that inhibit truA activity

  • Validation Studies: Confirmation that inhibition of truA reduces bacterial growth or virulence in cellular and animal models of infection

Current strategies for treating Legionella infections primarily rely on antibiotics like levofloxacin , so novel targets could address potential resistance issues.

How can cryo-EM be utilized to elucidate the truA-tRNA complex structure in L. pneumophila?

Cryo-electron microscopy (cryo-EM) offers significant advantages for studying the truA-tRNA complex, particularly when crystallization proves challenging. A comprehensive approach would include:

  • Sample Preparation Optimization:

    • Purify recombinant truA to >95% homogeneity

    • Reconstitute the complex with synthetic or in vitro transcribed tRNA substrates

    • Test various buffer conditions and protein:RNA ratios to achieve stable, homogeneous complexes

  • Data Collection Strategy:

    • Collect images at multiple defocus values to enhance contrast

    • Implement energy filters to improve signal-to-noise ratio

    • Utilize direct electron detectors for higher resolution

  • Image Processing Workflow:

    • Apply motion correction to mitigate beam-induced movement

    • Use reference-free 2D classification to identify homogeneous particle populations

    • Perform 3D reconstruction with validation through independent half-sets

This approach could reveal dynamic aspects of the recognition mechanism, similar to how TruB was found to employ both rigid docking and induced fit for substrate recognition . The resulting structural data would complement crystal structures (if available) by capturing multiple conformational states of the complex.

What are the most sensitive methods for detecting truA-mediated pseudouridylation in vivo?

Detecting truA-mediated pseudouridylation in vivo requires sophisticated approaches that can identify modified nucleosides within cellular RNA:

  • CMC-based Methods (Preferred for site-specific detection):

    • Treatment with N-cyclohexyl-N′-(2-morpholinoethyl)carbodiimide metho-p-toluenesulfonate (CMC) selectively reacts with pseudouridine

    • Reverse transcription stops at CMC-modified sites

    • Deep sequencing of cDNA products reveals modification sites genome-wide (Pseudo-seq)

  • Mass Spectrometry Approaches:

    • Liquid chromatography-tandem mass spectrometry (LC-MS/MS) for precise quantification

    • NAIL-MS (Nucleic Acid Isotope Labeling coupled with MS) to distinguish newly synthesized from pre-existing modifications

  • Antibody-based Detection:

    • Immunoprecipitation using anti-pseudouridine antibodies

    • Coupled with sequencing (Pseudo-IP-seq) to identify modified RNAs

These methods could be applied to compare wild-type L. pneumophila with truA knockout mutants to specifically identify truA-dependent modifications, potentially revealing unexpected substrates beyond the canonical targets in the anticodon loop.

How can molecular dynamics simulations predict the impact of point mutations in truA?

Molecular dynamics (MD) simulations provide powerful insights into the structural and functional consequences of point mutations in truA:

  • Simulation Setup:

    • Build homology models of L. pneumophila truA based on related crystal structures (like TruB )

    • Introduce specific point mutations in silico

    • Solvate the system with explicit water molecules and appropriate ions

  • Simulation Analysis:

    • Track changes in protein stability through RMSD (root-mean-square deviation) calculations

    • Monitor hydrogen bonding networks and salt bridges at the catalytic site

    • Analyze the flexibility of RNA binding regions through RMSF (root-mean-square fluctuation)

    • Perform free energy calculations to quantify changes in substrate binding affinity

  • Validation Experiments:

    • Express and purify the predicted critical mutants

    • Compare enzymatic activities with wild-type truA

    • Determine binding affinities through isothermal titration calorimetry or surface plasmon resonance

This integrated computational-experimental approach could identify residues critical for catalysis versus those important for substrate recognition, similar to how TruB was found to recognize its RNA substrate through specific structural elements like the "thumb loop" .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.